Table 4.
<28 weeks | ≥28 weeks | |||
---|---|---|---|---|
(i) | Male (n = 26) | Female (n = 17) | Male (n = 18) | Female (n = 25) |
Agalactosylation (%) | 15.0 ± 6.5 | 16.3 ± 6.1 | 12.4 ± 6.3 | 11.1 ± 4.2 |
Galactosylation (%) | 85.0 ± 6.5 | 83.7 ± 6.1 | 87.6 ± 6.3 | 88.9 ± 4.2 |
Terminal galactosylation (%) | 70.3 ± 3.7 | 69.6 ± 4.3 | 70.9 ± 5.5 | 70.1 ± 3.8 |
Sialylation (%) | 14.7 ± 3.5 | 14.1 ± 3.2 | 16.7 ± 4.0 | 18.8 ± 4.7 |
Bisection (%) | 8.8 ± 2.3 | 8.0 ± 1.8 | 11.1 ± 3.4 | 10.6 ± 2.2 |
(ii) | Preterm labor or AIS (n= 31) | All other causes (n= 12) | Preterm labor or AIS (n= 27) | All other causes (n= 16) |
Agalactosylation (%) | 15.2 ± 5.6 | 16.4 ± 8.0 | 11.3 ± 4.0 | 12.2 ± 6.9 |
Galactosylation (%) | 84.8 ± 5.6 | 83.6 ± 8.0 | 88.7 ± 4.0 | 87.8 ± 6.9 |
Terminal galactosylation (%) | 70.0 ± 3.4 | 70.0 ± 5.3 | 71.2 ± 3.7 | 69.3 ± 5.8 |
Sialylation (%) | 14.8 ± 3.0 | 13.6 ± 4.0 | 17.5 ± 4.1 | 18.6 ± 5.1 |
Bisection (%) | 8.3 ± 1.8 | 9.0 ± 2.8 | 9.8 ± 2.3 *** | 12.5 ± 2.7 |
(iii) | BPD (n= 14) | No BPD (n= 29) | BPD (n= 7) | No BPD (n= 36) |
Agalactosylation (%) | 17.0 ± 6.4 | 14.8 ± 6.2 | 16.9 ± 8.1* | 10.6 ± 3.8 |
Galactosylation (%) | 83.0 ± 6.4 | 85.2 ± 6.2 | 83.1 ± 8.1* | 89.4 ± 3.8 |
Terminal galactosylation (%) | 69.5 ± 4.2 | 70.3 ± 3.8 | 66.6 ± 5.4 | 71.2 ± 4.1 |
Sialylation (%) | 13.5 ± 2.9 | 14.9 ± 3.5 | 16.5 ± 4.6 | 18.2 ± 4.5 |
Bisection (%) | 8.4 ± 2.2 | 8.5 ± 2.1 | 10.9 ± 2.5 | 10.8 ± 2.8 |
(iv) | Sepsis (n= 27) | No sepsis (n= 16) | Sepsis (n= 11) | No sepsis (n= 32) |
Agalactosylation (%) | 16.6 ± 7.2 | 13.8 ± 3.9 | 14.8 ± 7.3 | 10.5 ± 3.8 |
Galactosylation (%) | 83.4 ± 7.2 | 86.2 ± 3.9 | 85.2 ± 7.3 | 89.5 ± 3.8 |
Terminal galactosylation (%) | 69.5 ± 4.6 | 70.8 ± 2.4 | 68.8 ± 5.5 | 71.1 ± 4.2 |
Sialylation (%) | 13.9 ± 3.5 | 15.4 ± 3.0 | 16.4 ± 3.7 | 18.4 ± 4.7 |
Bisection (%) | 8.7 ± 2.4 | 8.2 ± 1.6 | 12.1 ± 2.1 | 10.4 ± 2.8 |